Abstract: The biosynthesis of tRNA was investigated in cultured astroglial cells and the 3-day-old rat brain in vivo. In the culture system astrocytes were grown for 19 days and were then exposed to [3H]guanosine for 1.5-7.5 h; 3-day-old rats were injected with [3H] 3H]tRNA was followed through several stages of tRNA purification, including benzoylated DEAE-cellulose and reverse phase chromatography (RPC-5), and differences were found between the [3H]methylguanine composition of RPC-5 fractions containing, respectively, tRNALYs and tRNAPhe. The overall results of this study suggest that developing brain cells biosynthesize their particular complement of tRNAs actively and in a cell-specific manner, as attested by the significant differences in the labeling rates of their methylated guanines. The notion is advanced that cell-specific tRNA modifications may be a prerequisite for the successful synthesis of cell-specific neural proteins. 
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Hamberger (1971) incubated adult rabbit brain cortex slices in the presence of [3H]uridine and found the labeling of the glial RNA to be more pronounced than that of neuronal RNA. More recently, Kubat et al. (1978) examined the in vitro incorporation of [3H] uridine into RNA of rat brain glial-enriched fractions and discovered that a 6-day dietary restriction in protein intake specifically suppressed RNA labeling in the young animals used in the study. Yanagihara (1979) observed markedly higher rates of RNA formation in "intact" glial cells than in neuronal perikarya, a finding attributed to the preferentially reduced uptake by the perikarya of the RNA precursors, [3H]~ridine and [3H]-guanosine.
The specific biosynthesis of tRNA has also been studied in vivo, yet mostly as part of isotope incorporation studies involving other brain RNA species. However, Saborio and Aleman (1970) noted the exclusive labeling of tRNA for about 40 min following the intracerebral administration of [14C]uridine and ~-[Me-~H]methionine to 18-day-old rats, while Judes and Jacob (1973) described the dynamics of [3H]uridine incorporation into, inter alia, the tRNA of chick embryo brain extracts. More recently, Azcurra et al. (1975) demonstrated a rapid incorporation of [3H] uridine into the tRNA of 8-day-old rat brain neuronal perikarya, while Tewari et al. (1975) examined the effects of ethanol in vivo on the incorporation of [3H]oroti~ acid into mouse brain tRNA. Evidence from our laboratory has demonstrated the existence and the time course of formation of precursor tRNA molecules in the 3-day-old rat brain (Elahi and Sellinger, 1979) . We have also shown that homologous methylation of brain tRNA (Cummins et al., 1975) persists for up to 1 month after birth (Salas et al., 1976) and that many of the cerebral tRNA methyltransferases continue to alter their substrate recognition characteristics and hence their specificity for as long as 40 days postnatally Dainat et al., 1978; Dainat and Sellinger, 1980) .
In the present study we examine the biosynthesis of tRNA in two distinct neural systems, namely, cultured glial cells (astrocytes) and the 3-day-old rat brain in vivo.
EXPERIMENTAL PROCEDURES

Chemicals
DEAE-cellulose (DE23, Whatman) was from ReeveAngel, Clifton, New Jersey. For BDC-chromatography, Cellex-BD (100-200 mesh) was obtained from Bio-Rad, Richmond, California. For reverse-phase chromatography, the solid support material, was 
Animals
The 3-and 18-day-old rats were of the Sprague-Dawley strain. The 3-day-old animals were used at the earliest 24 h after arrival from the shippers (Spartan Farms, Haslett, Michigan). They were housed in cages containing one familykage.
Tissue Culture
All materials used were as previously described (Cummins and Glover, 1978; Cummins et al., 1979) . The cell culture procedure used in this study was also as previously described (Cummins and Glover, 1978) . However, the size of the culture dishes and hence of the surface area available for cell growth was varied to obtain the best conditions for maximum yields of Azso (absorbance units) and therefore of RNA. For RNA extraction, the cultures were handled as follows. The growth medium was decanted and the cells rinsed twice with phosphate-buffered saline containing (in g/liter): CaCl, and MgC12, 0.1; KCl and KH2P04, 0.2; NaCI, 8; and Na2HP04, 2.15. Equal volumes of TNE buffer (0.01 M -T~~s -H C~, pH 7.8, 0.1 M-NaCI, 0.01 M-NaEDTA) in DEPC-treated distilled water (0.5 ml DEPC/liter of water was boiled for 15 rnin and cooled), containing also 10 mM-MgC1, and pmercaptoethanol, pH 8.2, were mixed with TNEsaturated phenol. Ten milliliters of this mixture were used for transfer of the cells into a test tube which was agitated for 5 min on a Vortex Junior mixer, following the addition of 5 ml CHCI,. The extraction was continued in a shaking water bath, set to 60°C, for an additional 40 min. After centrifugation (9000 x g, 15 min), 3 vols. of 95% (v/v) EtOH were added to the separated aqueous layer and the RNA was allowed to precipitate overnight at -20°C. In the labeling experiments each 5 ml of growth medium also contained 62.5 pCi of [3H]guanosine. The 19-day-old cells were grown in 75-cm2 dishes and their RNA was extracted at intervals, as specified in the text.
In Vivo Labeling and Extraction of Brain tRNA
In these experiments, 4 pCi of [3H]guanosine/g of body weight was injected intracranially and the brains were removed for RNA extraction 5-45 rnin thereafter. The cerebral cortices were homogenized in 0.25 M-SUCTOSe containing 35 mM-Tris-HC1, pH 7.4, 25 mM-KCI and -MgCl,, 1 mM-sodium EDTA, 10 mM-P-mercaptoethanoi and 0.05% DEPC. The homogenate was centrifuged for 20 rnin at 30,000 X g; the low-molecular-weight RNA was extracted from the resulting supernatant by the procedure of Ortwerth and Der (1974) .
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Purification, Hydrolysis, and Compositional Analysis of tRNA
Following extraction the RNA was precipitated with ethanol and, as above for astrocyte RNA, it was stored overnight at -20°C. Following centrifugation, it was redissolved in 10 mM-Tris-HC1, containing 10 mM-MgC1,, 1 mM-EDTA, and 50 mM-NaC1, pH 7.5 (buffer A), and the sample was loaded on a column of DEAE-cellulose previously equilibrated with buffer A. Elution with buffer A was continued until the reading fell below 0.05. Next, the column was rinsed with buffer A containing 0.3 MNaCl until an Aze0 reading of 0.05 was reached. Finally, the tRNA-containing fraction was eluted with buffer A containing 0.7 M-NaCI. The tubes exhibiting &60/A,2L80 Values in excess of 1.5 were pooled and dialyzed to remove NaCl. Following lyophilization, the tRNA was hydrolyzed in trifluoracetic acid (Klagsbrun, 1972) Salas and Sellinger (1977) . To achieve the separation of guanine from 1-methylguanine and of the latter base from the remaining [SH]methylguanines, 50 mM-ammonium phosphate + 1 M-NH,CI in 10% (vlv) methanol was used as the single eluting buffer. The hydrolysis and HPLC separation of guanine from its methylated derivatives remained unchanged for tRNA preparations of higher purity (see text for details) than the material exiting from DEAE-cellulose.
Benzoylated-DEAE-Cellulose Chromatography
Chromatography on benzoylated DEAE-cellulose (BDC) was performed for further purification of tRNA and for the isolation of tRNAPhe and tRNAIYS. Cellex-BD was washed and the column ( 1 x 20 cm) was packed and prepared for use according to Roy et al. (1971) . The equilibrating buffer was 50 mM-sodium acetate, pH 5.0, containing 10 mM-MgC1, and 0.3 M-NaCI. tRNA (up to 200 A,,, units) , dissolved in the equilibrating buffer, was loaded and the elution was carried out with 120 ml of a 0.5 -1.0 M-NaCl gradient in the above buffer, followed by 120 ml of a 0-30% (vlv) ethanol gradient containing 1 M-NaCl in buffer, The flow rate was adjusted to 2 mumin and 5-ml fractions were collected. All solutions used in BDC chromatographic work also contained 0.04% sodium azide. Aliquots (0.1 ml) of each effluent fraction were mixed with scintillant and their radioactivity was determined. Up to 0.5 ml was taken for the aminoacylation assay (see below).
RPC-5 Chromatography
The procedure described by Kelmers and Heatherly (1971) was adapted to a 0.9 x 50 cm column which was operated at approx. 250 psi. Elution was carried out using 200 ml of a gradient of 0.5-1.0 M-NaCI prepared in 10 mM-sodium acetate, 10 mM-MgCl,, 1 mM-EDTA, and 30 mM-0-mercaptoethanol, pH 4.5.
Preparation of Aminoacyl-tRNA Synthetases
Livers or brains (approx. 10 g) of adult rats were homogenized in 2 volumes of buffer containing 0.25 Msucrose, 50 mM-KCI, 10 mM-Tris-HCI, pH 7.5, 10 m MMgClz, 0.01 mM-P-mercaptoethanol, and 10% (vlv) glycerol. The homogenate was centrifuged as above for tRNA extraction and the supernatant was recentrifuged for 75 min at 160,000 x g. The resulting supernatant (10-30 ml) was passed through a column of Sephadex G-75 (2.5 x 75 cm) previously equilibrated with Tris-HCI (50 mM, pH 7.51, containing 10 mM-KCI, -MgCI,, and -P-mercaptoethanol and 10% glycerol. Elution was at 1 m1/3 min and fractions of 3.5 ml were collected. Fractions 23-25 were stored a t -20°C following addition of glycerol to 50% (v/v).
tRNA Aminoacylation
After chromatography on BDC or RPC-5 (post-charging)
tRNA was aminoacylated in a reaction volume of 1 ml containing in order of addition: 1 gCi of '*C or 3H amino acid, 0.4 M-Tris-HCI, pH 7.5, 10 (for lysine) or 20 (for phenylalanine) mM-MgCI,, 20 (for lysine) or 50 (for phenylalanine) mM-KCI, 1 (for lysine) o r 4 (for phenylalanine) mM-ATP, 0.6 mM-CTP, 2 mM-@ mercaptoethanol, 0.1-0.5 AZ6,) units of tRNA and approx. 1 mg of hepatic or cerebral aminoacyl-tRNA synthetase protein. Following incubation for 10 min, at 37°C and with gentle shaking, the reaction was stopped by placing the tubes on ice, adding 5 ml of ice-cold 10% trichloroacetic acid and collecting the radioactive aminoacyl-tRNA on Whatman GFIA filters, which were processed for counting according to Yang and Novelli (1971) .
Before chromatography on BDC or RPC-5 (pre-charging)
This was carried out on amounts of tRNA in excess of 1 A260 unit in a final volume of 1 ml, containing 1-5 p.Ci of amino acid, 0.2 ~-Tris-HCl, pH 7.5, 10 mM-MgCl,, 20 mM-KCI, 1 mM-ATP, 3 mM-CTP, 8 mM-/3-mercaptoethanol, and 10-15 mg of hepatic aminoacyl-tRNA synthetase protein. The tRNA was not deacylated before use because it was of primary interest to determine the acceptance capacity of the available, "native," uncharged tRNA species.
Protein Determination
The procedure of Lowry et al. (1951) was used with crystalline bovine serum albumin as standard.
RESULTS
Optimization of Growth Conditions for
Maximal RNA Yields
The examination of the effect of the surface area of the culture dish and of time. of culture on the yield of extractable A,,,, units/20 dishes resulted in maximal yields after 19 days in 75-cm2 dishes. Cultures so grown were exposed to [3H]guanosine (see Methods) for 0.5-7.5 h and, at intervals, total RNA was extracted and its radioactivity determined. lagged at first and then increased to near-maximal levels between the 3rd and 4th h. Figure 1 , B indicates a more gradual labeling pattern for tRNA. As shown by Fig. 1 , C, the percentage of labeled tRNA relative to the total RNA peaked at 3 h. The specific radioactivity of astrocyte tRNA (Fig. 1, D) appeared to increase in parallel with the increase in its labeling.
Aminoacylation of Brain and Astrocyte tRNA
To assess the functional capacity of tRNA with respect to lysine and phenyialanine, preparations of astroglial and cerebral tRNA were charged with [l4C]pheny1alanine and [14C]lysine in assays employing both hepatic and cerebral aminoacyl tRNA-synthetase preparations. Table 1 indicates maximum charging under the heterologous condition, i.e., when liver enzyme catalyzed the aminoacylation of brain tRNA. Minimal charging values were obtained under conditions approximating homology, i.e., when brain enzyme catalyzed the aminoacylation of the presumably cell-specific glial tRNA. It is of interest to note that the aminoacylation of phenylalanine was uniformly inferior to that of lysine, particularly when astrocyte tRNA was the substrate. Closer inspection of the values in Table 1 further reveals that, whereas astrocyte tRNA was between 20-and 30-fold less efficient than brain tRNA in phenylalanine acceptance (compare 4.34 and 0.21 and 1.78 and 0.064 pmol), lysine acceptance by astrocyte tRNA was only three-to fivefold lower than by brain tRNA.
Incorporation of [ 3 H ] G u a n~~i n e into Astrocyte tRNA
Astrocyte tP"4 labeled for 1-3,4, and 7.5 h was hydrolyzed to its 3H bases, which were separated by HPLC and assayed for radioactivity. Figure 2 shows the radioactivity profile of a typical separation after 7.5 h of exposure of the astrocytes to [3H]guanosine. Table 2 lists: (a) the distribution of 3H between guanine and the four principal [31-2]-methyl guanines (1-, 7-, N2-methyl, and N,2-dimethyl guanine) as a function of time in culture (columns 1 and 2); (b) the distribution of 3H among the four methylated guanines (columns 3-6); and (c) the percent of radioactivity in the four methylated guanines, after normalizing the sum of their radioactivity to 100% (values in parentheses). It may be seen that the labeling of guanine and of the methyl guanines remained sustained throughout the [3H] 1-Methylguanine was maximally labeled within the first 3 h, but by 7.5 h its radioactivity had decayed to half of its early value. The incorporation of [3H]guanosine into [3H]N2-methylguanine more than doubled between 1-3 and 7.5 h, whereas that entering [3H]N%-dimethylguanine increased about six-and fourfold relative to the overall and the methyl guanine radioactivities, respectively. These results indicate a rather independent temporal pattern of labeling of each methylguanine.
Incorporation of [3H]Guanosine into Brain tRNA In Vivo
Three-day-old rats were injected intracranially with [3H]guanosine (see Methods); groups of 10 animals were killed 5, 10, 20, and 45 min later. The brain tRNA was extracted and purified by DEAEcellulose chromatography, and its radioactivity and AZ6dAzso absorbance ratio were determined. The average yield of tRNA in the 0.7 M-NaCl DEAEcellulose effluent was 5 A260 units/g of brain or about 2.2 A,,, units per brain. The f3H]tRNA was further purified by BDC chromatography, resulting in two separate fractions, a "salt" fraction (eluted with a gradient of 0.5-1.0 M-NaC1, pH 5.0) and an "ethanol-salt'' fraction (eluted with a gradient of 0-30% v/v EtOH in 1 M-NaCl, pH 5.0). About 85% of the recovered A260 units was found in the "salt" and the remaining 15% in the "ethanol-salt'' fraction. Table 3 shows the specific radioactivity (s.r.a.) of the [3H]tRNA and Fig. 3 Fig. 3 , 3-day-old rat brain has three tRNAIYS isoacceptors, the most abundant one of which was eluted in the "salt" fraction, while the two minor isoacceptor species were eluted in the "ethanol-salt" fraction, which also contained all of the tRNAPhe isoacceptors. Total tRNA labeling (d.p.rn./&,,) appeared to increase about sixfold between 5 and 45 min ( Table 3 , row 1). Labeling of the tRNA species resolved by BDC chromatography (rows 2 and 3, Table 3 ), appeared to proceed more slowly and at different rates in the "salt" versus the "ethanol-salt'' fraction. Moreover, the "ethanol-salt'' fraction contained tRNAs of much higher relative purity than the "salt" fraction, as indicated by the "ethanolsalt"/' 'salt" ratios.
As above with the [3H]tRNA from astrocytes ( 
Attempts to Isolate tRNAPhe from Rat Brain
In order to obtain more reliable information about the pattern of labeling of tRNA guanine and methyl guanine residues, and also to assess the feasibility of isolating a single labeled tRNA species, a largescale experiment was carried out in which 53 3-day-old rats were injected with 45 min later. Portions of the DEAE-cellulose and of the "salt" and "ethanol-salt" BDC effluent fractions, as well as three pools of the RPC-5 effluent, were subjected to total hydrolysis and subsequent HPLC. In this fashion, it became possible to follow
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tRNA at different stages of the tRNAphe purification procedure. The results ( Table 5 ) reveal significant differences in composition between the three RPC-5 subfractions and they also disclose an apparent similarity between the BDC "salt" and "ethanol-salt'' fractions. The RPC-5 fraction containing the tRNA with peak acceptance for phenylalanine (fraction I) appeared to contain a higher proportion of labeled 7-and Nidimethylguanine than its neighbor and no detectable labeled 1-and N2-methylguanine. Fraction I1 contained all but [3H]7-methylguanine, while fraction I11 resembled the [3H]tRN&he-~~ntaining fraction I, yet had a much lower [3H]Nq-dimethylguanine content.
Methyl Guanine Labeling Patterns in
Astrocyte and Brain tRNA
Although in this study we monitored the biosynthesis of tRNA both in the 3-day-old rat brain and in fully differentiated astrocytes derived from the 3-day-old rat brain, a direct comparison of the labeling patterns of the methylated guanines in the two neural systems is not possible, principally because of the different temporal parameters governing their formation, hours in astrocytes and minutes in the live animal. Yet, while the labeling of l-methyl- (1930 pmoUA,,,) in tube 11, in which phenylalanine acceptance was nil. Phenylalanine acceptance was 17.5 pmoUA,,, in tube 50, in which lysine acceptance was nil. No phenylalanine or lysine acceptance was detected in tubes 54-80. guanine was very rapid and intense in astrocyte tRNA, and virtually nonexistent in brain tRNA, that of N2-methylguanine appeared to be characteristic for each of the two systems under study (Fig. 4) .
DISCUSSION
The exposure of the astrocytes to [3H]guanosine resulted in a very low degree of incorporation of 3H into cellular RNA during the initial 3 h. The rate of labeling increased, however, between the 3rd and 4th h, abating considerably thereafter. Figure 1, parts B and C, indicates that the labeling and the specific radioactivity of tRNA increased gradually from the very start and did so, apparently, in the face of a progressive decrease, past hour 3, in the proportion of the radioactivity incorporating into tRNA, as opposed to total RNA. At present we have no explanation for the sharp decrease in the ratio of labeled tRNA to total RNA shown by Snyder et al. (1978) and May and Hoffee (1 978) with neuroblastoma and Novikoff hepatoma cells, it is not known whether the normal astrocytes used in this study possess specialized high-affinity mechanisms for the uptake of guanosine, as they do for adenosine (Hertz, 1978) . It is of interest, however, that Yanagihara (1979) found the uptake of 1 PMguanosine into bulk-isolated rabbit cortex glial cells to be 6.5-fold more effective than it is into "intact" neuronal perikarya.
The partially purified astrocyte and brain tRNAs were aminoacylated under assay conditions optimized with brain tRNA for lysine and phenylalanine acceptance with regard to [ Mg2+], [ K+] , and [ATP] (Johnson and Chou, 1973) . Table 1 indicates significantly lower acceptance values for lysine and phenylalanine with astrocyte than with brain tRNA, irrespective of the source of the aminoacyl-tRNA synthetase. Yet, lysine and phenylalanine acceptance was higher in the presence of the hepatic enzyme, with either kind of tRNA, in confirmation of results of others (Barra et al., 1972; Johnson and Chou, 1973; Harris and Maas, 1974) . Moreover, a homologous lysine acceptance of 22.4 prnoVA,,dmg protein by 3-day-old rat brain tRNA ( (Barra et al., 1972) ] agreed less well. No adequate explanation for the low acceptance values of astrocyte tRNA is available at this time; however, the assays were not individually optimized owing to its relatively low availability and the fact that the tRNA preparations were not deacylated before use. Since the acceptance values were derived from tRNAs of cells grown in culture for 19 days, they ought to be compared to older than 3-day-old rat brain tRNA acceptance values and these, as shown by Barra et al. (1972) , do decrease appreciably between 4 and 55 days of postnatal life.
The results of the experiments on the incorporation of [3H]guanosine into neural tRNAs (Tables 2 -5) reveal that cultured astrocytes and immature brain are well suited for investigations of the cellspecific nature of tRNA biosynthesis and modification. Since, relative to the tRNA of 3-day-old brain (Table 4) , which reflects a largely neuronal cellular template, astrocyte tRNA (Table 2) showed a significantly higher ratio of methylated to unmodified guanine(s), it is possible to suggest that the incorporation results mirror real, albeit subtle, differences in methyl guanine content between some, if not all, glial and neuronal tRNAs. Supportive evidence for this notion may be seen in the distribution of the individual [3H]methyl guanines within astrocyte and brain tRNA at the end of their respective labeling periods (45 min versus 7.5 h). Although [3137-and N2-methylguanine appeared to predominate in both 0 . Z . SELLINGER AND 0 . DER tRNAs and accounted for up to 80% of the total [3H]methyl guanines, the remaining 20-25% was shared by [ 3H]N$dimethyl-and L3H] l-methylguanine in astrocyte tRNA; but significantly the latter species was never detected in: (a) bulk brain tRNA (Table 4) ; (b) RPC-5 fraction I (Table 5 ) , containing tRNAs with the highest phenylalanine and lysine acceptance capacities and (c) RPC-5 fraction 111, which contained no tRNAphe or tRNAIYS. Interestingly, however, [ 311] 1-methylguanine was present in RPC-5 fraction 11, which contained some tRNAPhe, no tRNAIYS, and, unlike fractions I and 111, no [ 3H] 7-methylguanine. RPC-5-chromatography of the BDC "ethanol-salt" fraction of 3-dayold rat brain tRNA thus proved effective in separating tRNAs containing [3HJ 1-methylguanine from those containing [3H] 7-methylguanine.
As a result of our continued interest in neural tRNA during development, it is now clear that tRNA biosynthesis and tRNA methylation are cellspecific. Each process can be studied in vivo (this paper), in whole brain minces (Elahi and Sellinger, 1979) , in brain regions (Sellinger et al., 1979; Dainat and Sellinger, 1980) , and in specific cell types, bulk-isolated (Salas and Sellinger, 1978) or grown in culture (this paper). A sustained and correct structural adjustment of neural tRNAs thus appears as a prerequisite for the successful synthesis of those neural proteins which are essential for the acquisition of a particular neural function at a precise and nonrecurrent time during brain development.
